VALN - Pfizer adds bull at Guggenheim on ex-COVID prospects February, 23 2024 08:39 AM Valneva SE 2024-02-23 08:39:04 ET More on Pfizer Pfizer's Post-Pandemic Pivot Pfizer: Turnaround Is Gaining Momentum Pfizer Stock: It's Time To Buy The Dip Obesity drugs to expand U.S. GDP by 1% in the coming years: Goldman Sachs Pfizer to settle Lipitor antitrust lawsuit for $93M For further details see: Pfizer adds bull at Guggenheim on ex-COVID prospects